Regulator scams, some using fake signatures of Finra executives, have been growing.
There's no hard-and-fast rule, but too many can overwhelm participants and breed bad decisions.
Elimination of the tax break divorcees get for paying alimony gives them less incentive to be generous to their former spouse.
Following a change to the treatment of alimony, respondents said they expect divorce negotiations to become more acrimonious.
Client invested $20,000 in a real estate investment controlled by the broker, who later used the money for his own personal use.
Action of Massachusetts' top regulator shows states can put teeth into a rule under review by the Trump administration.
State and federal inquiries promise to drag on for months.
Brokerage firms would no longer be able to charge reps for supervising nonaffiliated RIAs.
Plan sponsors will get access to Financial Engines' full suite of managed-account services and improved technology integration.
Who information security professionals report to can impact investment and response.
Lower tax rates make it more advantageous to fully fund pension plans, often a prerequisite to conducting a pension risk transfer.
Massachusetts securities regulator says Thomas Riquier defrauded investors while son-in-law supervised.
Advisers who have clients' best interests at heart should insist upon the disclosure of actual internal policy costs and performance.
Companies like Everplans and Yourefolio are finding success with advisers looking to expand their planning capabilities.
Plan sponsors are risk-averse, so 401(k) advisers should highlight the benefits of new concepts while trying to minimize the risk, work and costs.
Allowing in-plan Roth conversions and periodic distributions are among the changes plans could make to better serve older employees.
The DOL fiduciary rule and excessive-fee lawsuits are combining to raise the profile of fiduciary retirement plan advisers.
Agency has the ability to detect share-class issues using data-driven initiatives.
Tibor Klein also will pay $20,000 fine for trading on 2010 Pfizer acquisition.
